Discrimination of two different clinical entities, acute-type and subacute-type, human fulminant hepatitis by peripheral blood lymphocyte subsets

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 3, 1999, Pages 274-280

  Shimizu, Takeshi ^a   Tokushige, Katsutoshi ^a   Yamaguchi, Naoko ^a   Ishikawa, Kayo ^a   Hasegawa, Kiyoshi ^a   Yamauchi, Katsumi ^a   Hayashi, Naoaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Fulminant hepatitis; Lymphocyte subsets

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATIC COMA; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; IMMUNOCYTOCHEMISTRY; LIVER INJURY; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MORTALITY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SEROPREVALENCE; T LYMPHOCYTE;

EID: 0032923013     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01850.x     Document Type: Article

References (22)

1. 1 Takahashi Y, Shimizu M. The study group of fulminant hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentre study. J. Gastroenterol. Hepatol. 1991; 6: 159-64.
2. 2 Ishikawa K, Hasegawa K, Kojima T et al. HGV is a rare but possible causative agent of non A-C fulminant hepatitis. Hepatology 1996; 24 (Suppl.): 527A.
3. 3 Gimson AES, White YS, Eddleston ALWF, Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut 1983; 24: 1194-8.
4. 4 Yoshiba M, Dehara K, Inoue K, Okamoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology 1994; 19: 829-35.
5. 5 O'Gray JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-5.
6. 6 Buschenfelde K-HMZ, Mann M. Mechanisms of autoimmune liver disease. Semin. Liver. Dis. 1984; 4: 26-35.
7. 7 Van Hattum J, Van Oudenaren A, Schalm SW, Visser JWM, Benner R. T-lymphocyte subpopulation in patients with various courses after hepatitis B virus infection. Scand. J. Gastroenterol. 1984; 19: 497-501.
8. 8 Wands JR, Perrotto JL, Alpert E, Isselbacher KJ. Cell mediated immunity in acute and chronic hepatitis. J. Clin. Invest. 1975; 55: 921-9.
9. 9 Sun Y, Tokushige K, Isono E, Yamauchi K, Obata H. Elevated serum interleukin-6 levels in patients with acute hepatitis. J. Clin. Immunol. 1992; 12: 197-200.
10. 10 Muto Y, Nouri-Aria KT, Meager A, Alexander GJM, Eddleston AL, Williams R. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 9: 72-4.
11. 11 Hasegawa K, Yamauchi K, Furukawa T, Obata H. Dual color fluorescence analysis of peripheral T cell subsets in hepatitis B virus-induced liver disease. Hepatology 1988; 8: 1134-7.
12. 12 Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis. Hepatology 1996; 23: 389-95.
13. 13 Okamoto H, Okada S, Sugiyama H et al. Detection of hepatitis C virus by two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. J. Gastroenterol. Hepatol. 1991; 6: 159-64.
14. 14 Clement LT, Grossi CE, Gartland GL. Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. J. Immunol. 1984; 133: 2461-8.
15. 15 Clement LT, Dagg MK, Landay A. Characterization of human lymphocyte subpopulations: alloreactive cytotoxic precursor and suppressor cells. J. Clin. Immunol. 1984; 4: 395-402.
16. 16 Landay A, Gartland GL, Clement LT. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J. Immunol. 1983; 131: 2757-61.
17. 17 Regenstein FG, Rooman ST, Perrillo RP. Immunoregulatory T cell subsets in chronic hepatitis B virus infection: the influence of homosexuality. Hepatology 1983; 3: 951-4.
18. 18 Barnaba V, Zaccari C, Levreo M, Rucco G, Balsano F. Immunoregulatory T cells in HBV-induced chronic liver disease as defined by monoclonal antibodies. Clin. Immuno. Immunopathol. 1983; 26: 83-90.
19. 19 Dudley FL, Fox RA, Sherlock S. Cellular immunity and hepatitis-associated Australian antigen liver disease. Lancet 1972; 1: 723-6.
20. 20 Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M. Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 1996; 111: 156-64.
21. 21 Ryo K, Kamogawa Y, Miyazono Y et al. A possible role of Fas mediated apotosis in human fulminant hepatitis. Gastroenterology 1997; 112: A1369.
22. 22 Owen-Schaub LB, Yonehara S, Crump III WL, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 1992; 140: 197-205.